Trials / Completed
CompletedNCT03405584
High Dose of Dual Therapy Plus Bismuth for Helicobacter Pylori Treatment
Efficacy of High Dose of Dual Therapy Plus Bismuth for Helicobacter Pylori Treatment：a Randomized Clinical Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 160 (actual)
- Sponsor
- Shanghai Jiao Tong University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Dual therapy for Helicobacter Pylori including a proton pump inhibitor (PPI) and amoxicillin. Amoxicillin has low resistance rate as well as low percentage of side effects. No trial has examined the the efficacy of high dose of dual therapy plus bismuth for H. pylori treatment.This study is designed to evaluate the efficacy and safety of the addition of bismuth to high dose of dual therapy for H. pylori eradication.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Esomeprazole | Proton pump inhibitor |
| DRUG | Amoxicillin | Antibiotic for H. pylori eradication |
| DRUG | Bismuth Potassium Citrate | Gastric mucosal protective drug with anti-H. pylori effect |
Timeline
- Start date
- 2018-01-03
- Primary completion
- 2018-11-02
- Completion
- 2018-11-02
- First posted
- 2018-01-23
- Last updated
- 2018-11-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03405584. Inclusion in this directory is not an endorsement.